About the Authors
- Kate Stuart
-
Contributed equally to this work with: Kate Stuart, John Paderi
Affiliation Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana, United States of America
- John Paderi
-
Contributed equally to this work with: Kate Stuart, John Paderi
Affiliation Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana, United States of America
- Paul W. Snyder
-
Affiliation School of Veterinary Medicine, Purdue University, West Lafayette, Indiana, United States of America
- Lynetta Freeman
-
Affiliations Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana, United States of America, School of Veterinary Medicine, Purdue University, West Lafayette, Indiana, United States of America
- Alyssa Panitch
-
* E-mail: apanitch@purdue.edu
Affiliation Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana, United States of America
Competing Interests
Authors Kate Stuart, John Paderi, Alyssa Panitch, and Lynetta Freeman are inventors on patents to the peptidoglycan technology and are founders of Glytrix, LLC, which holds exclusive option to the peptidoglycan technology, and was awarded SBIR funding, supporting part of the work herein. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: KS JP LF AP. Performed the experiments: KS JP PS LF. Analyzed the data: KS JP PS. Contributed reagents/materials/analysis tools: KS JP PS AP. Wrote the paper: KS JP LF AP.